Case of subcutaneous insulin resistance syndrome treated with ultra-rapid insulin lispro

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Subcutaneous insulin resistance syndrome is a rare condition that causes difficulty in glycemic control due to severe resistance to subcutaneous insulin injections. We herein present a case of a 40-year-old woman with type 2 diabetes mellitus who had been diagnosed with subcutaneous insulin resistance syndrome since the age of 29 years, and had been persistently treated with continuous subcutaneous insulin infusion using a mixture of insulin lispro and heparin. The patient was switched from insulin lispro plus heparin to ultra-rapid insulin lispro; given that it contains treprostinil and citrate, it is expected to have similar effects as heparin, and shows similar glucose-lowering effects and insulin absorption. Our results suggest that treatment with ultra-rapid insulin lispro is effective for subcutaneous insulin resistance syndrome.

Cite

CITATION STYLE

APA

Ishii, T., Katayama, A., Sue, M., Kuribayashi, R., Tenta, M., Matsushita, Y., … Hida, K. (2022). Case of subcutaneous insulin resistance syndrome treated with ultra-rapid insulin lispro. Journal of Diabetes Investigation, 13(3), 588–591. https://doi.org/10.1111/jdi.13667

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free